Endo International | Capitale Sociale E Riserve



Capitale Sociale E Riserve Cambiamento Data
AbbVie USD -2.64B 2.46B 2025-09
Amarin USD 458.89M 6.03M 2025-09
ANI Pharmaceuticals USD 505.82M 69.06M 2025-09
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Coherus Biosciences USD 87.77M 32.05M 2025-09
Eli Lilly USD 26.54B 2.74B 2025-12
Heron Therapeutics USD 14.88M 42.14M 2025-09
Hikma Pharmaceutical USD 2.55B 230M 2025-06
Ligand Pharmaceuticals USD 950.17M 121.64M 2025-09
Merck USD 51.85B 2.79B 2025-09
Novartis USD 44.75B 2.7B 2025-09
Pacira USD 727.21M 30.55M 2025-09
Perrigo USD 4.45B 25.8M 2025-09
Pfizer USD 92.8B 4.11B 2025-09
Phibro Animal Health USD 332.36M 20.68M 2025-12
Supernus Pharmaceuticals USD 1.05B 14.23M 2025-09
Takeda JPY 7.64T 513.39B 2025-12
Teva Pharmaceutical Industries USD 7.91B 664M 2025-12
Xeris Pharmaceuticals USD -861K 18.44M 2025-09
Zoetis USD 3.33B 2.07B 2025-12


Endo International Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.